Summary of CV and Renal Outcomes with SGLT2i and DPP4i Agents SGLT2: Inhibitor Cardiovascular Outcome Trials Cardiovascular outcome trials (CVOTs) have consistently shown that treatment with SGLT2i reduces hospitalization for heart failure (HHF) and secondary renal outcomes in terms of incident or worsening nephropathy in patients with T2DM and CV disease
If you have already had your gallbladder removed, this specific risk is no longer a concern for you
As companies race to acquire GLP-1 therapies, they are looking beyond traditional M&A structures to joint ventures, licensing agreements as well as acquiring production facilities and manufacturing sites across the world
For a GLP-1 agonist such as a semaglutide like Ozempic, the lowest dose for starting is usually 0.25 milligrams weekly, says Richard Siegel, MD, codirector of the Diabetes and Lipid Center at Tufts Medical Center
Alcohol adds empty calories, pauses fat-burning, disrupts blood sugar, and loosens food restraint, all of which work against the way GLP-1 medications help you lose weight
Focus on including something from each category each day, and stay attentive to how different combinations make you feel